1. Home
  2. NEXR vs NXTS Comparison

NEXR vs NXTS Comparison

Compare NEXR & NXTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nexera Technologies Ltd Ordinary Shares

NEXR

Nexera Technologies Ltd Ordinary Shares

SELL

Current Price

$1.12

Market Cap

615.5K

ML Signal

SELL

Logo Nexentis Technologies Inc. Common Stock

NXTS

Nexentis Technologies Inc. Common Stock

SELL

Current Price

$1.72

Market Cap

699.8K

Sector

Industrials

ML Signal

SELL

Company Overview

Basic Information
Metric
NEXR
NXTS
Founded
2021
2009
Country
Israel
Israel
Employees
N/A
N/A
Industry
Other Specialty Stores
Agricultural Chemicals
Sector
Consumer Discretionary
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
615.5K
699.8K
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
NEXR
NXTS
Price
$1.12
$1.72
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 6.9M
145.4K
Earning Date
08-14-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $263,445.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.21
$0.43
52 Week High
$5.28
$53.90

Technical Indicators

Market Signals
Indicator
NEXR
NXTS
Relative Strength Index (RSI) 48.86 55.71
Support Level $0.91 $1.28
Resistance Level $1.84 $1.66
Average True Range (ATR) 0.21 0.20
MACD 0.01 0.04
Stochastic Oscillator 42.22 51.92

Price Performance

Historical Comparison
NEXR
NXTS

About NEXR Nexera Technologies Ltd Ordinary Shares

Nexera Technologies Ltd focuses on homeland security technologies, artificial intelligence-driven solutions, and detection systems through its subsidiaries and strategic collaborations. The company collaborates with technology partners to distribute and promote new systems such as 3D imaging and electromagnetic threat detection tools, autonomous security technologies, and multi-layered security ecosystems for critical infrastructure and high-traffic venues.

About NXTS Nexentis Technologies Inc. Common Stock

Nexentis Technologies Inc, is engaged in redefining mitochondrial drug discovery with help of its wholly owned biotechnology subsidiary, MitoCareX Bio focused on drug discovery company dedicated to developing first-in-class therapeutics for inflammatory metabolic diseases and cancer by targeting specific metabolic pathways. The company is also focused on sustainable operations in various industries such as solar projects, and oncology biotechnology.

Share on Social Networks: